Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Edwards

Showing results (91-100 of 118) with videos related to

Pageof 12
Sort By:
Lancet (London, England)|August 25, 1973
Low-dose urokinase in major pulmonary embolismI R Edwards, K S MacLean, J D Dow
British Journal of Rheumatology|May 1, 1985
Pharmacokinetic projections for isoxicam and piroxicam in old and young subjectsA J Campbell, D G Ferry, I R Edwards
The New Zealand Medical Journal|April 21, 1999
Mirtazapine and the granulocytes--so far so goodR H Meyboom, I R Edwards, A C Egberts
The British Journal of Dermatology|December 1, 1974
Parenteral nutritionR G Clark, S S Bleehen, I R Edwards
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1989
Teratogenicity of combinations of sodium dichromate, sodium arsenate and copper sulphate in the ratR W Mason, I R Edwards, L C Fisher
Pharmacoepidemiology and Drug Safety|June 2, 2004
Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring DatabaseM Ståhl, M Lindquist, I R Edwards, et al.
Lancet (London, England)|July 21, 1990
Quality criteria for early signals of possible adverse drug reactionsI R Edwards, M Lindquist, B E Wiholm, et al.
British Journal of Clinical Pharmacology|May 1, 1987
Captopril: 4 years of post marketing surveillance of all patients in New ZealandI R Edwards, D M Coulter, D M Beasley, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven daysB R Dobbs, L R Gazeley, I A Stewart, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patientsL J Schaaf, B R Dobbs, I R Edwards, et al.
Pageof 12

Showing results (91-100 of 118) with videos related to

Sort By:
Pageof 12
Lancet (London, England)|August 25, 1973
Low-dose urokinase in major pulmonary embolismI R Edwards, K S MacLean, J D Dow
British Journal of Rheumatology|May 1, 1985
Pharmacokinetic projections for isoxicam and piroxicam in old and young subjectsA J Campbell, D G Ferry, I R Edwards
The New Zealand Medical Journal|April 21, 1999
Mirtazapine and the granulocytes--so far so goodR H Meyboom, I R Edwards, A C Egberts
The British Journal of Dermatology|December 1, 1974
Parenteral nutritionR G Clark, S S Bleehen, I R Edwards
Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology|January 1, 1989
Teratogenicity of combinations of sodium dichromate, sodium arsenate and copper sulphate in the ratR W Mason, I R Edwards, L C Fisher
Pharmacoepidemiology and Drug Safety|June 2, 2004
Introducing triage logic as a new strategy for the detection of signals in the WHO Drug Monitoring DatabaseM Ståhl, M Lindquist, I R Edwards, et al.
Lancet (London, England)|July 21, 1990
Quality criteria for early signals of possible adverse drug reactionsI R Edwards, M Lindquist, B E Wiholm, et al.
British Journal of Clinical Pharmacology|May 1, 1987
Captopril: 4 years of post marketing surveillance of all patients in New ZealandI R Edwards, D M Coulter, D M Beasley, et al.
The Journal of Antimicrobial Chemotherapy|February 1, 1988
Pharmacokinetics and sputum penetration of enoxacin after twice daily oral dosing for seven daysB R Dobbs, L R Gazeley, I A Stewart, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Nonlinear pharmacokinetic characteristics of 5-fluorouracil (5-FU) in colorectal cancer patientsL J Schaaf, B R Dobbs, I R Edwards, et al.
Pageof 12